Cargando…

Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia

The cholesterol metabolism in humans can be indirectly reflected by measuring cholesterol metabolism marker levels. We aimed to investigate the association of cholesterol homeostasis markers on standard lipid profiling components in familial hypercholesteremia and hyperlipidemia patients. A total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhi-Zhao, Huang, Qiong, Yang, Xiao-li, Zeng, Jieqiong, Wang, QI-Hui, Tang, Hai-Ming, Yu, Zhen-qiu, Song, Yu-Qing, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050270/
https://www.ncbi.nlm.nih.gov/pubmed/35493299
http://dx.doi.org/10.1155/2022/2008556
_version_ 1784696324078174208
author Li, Zhi-Zhao
Huang, Qiong
Yang, Xiao-li
Zeng, Jieqiong
Wang, QI-Hui
Tang, Hai-Ming
Yu, Zhen-qiu
Song, Yu-Qing
Liu, Yang
author_facet Li, Zhi-Zhao
Huang, Qiong
Yang, Xiao-li
Zeng, Jieqiong
Wang, QI-Hui
Tang, Hai-Ming
Yu, Zhen-qiu
Song, Yu-Qing
Liu, Yang
author_sort Li, Zhi-Zhao
collection PubMed
description The cholesterol metabolism in humans can be indirectly reflected by measuring cholesterol metabolism marker levels. We aimed to investigate the association of cholesterol homeostasis markers on standard lipid profiling components in familial hypercholesteremia and hyperlipidemia patients. A total of 69 hyperlipidemia patients, 25 familial hypercholesteremia (FHC) patients, and 64 healthy controls were enrolled in this study. We performed routine testing of blood lipid water. Gas chromatography was used to determine the changes in the concentration of cholesterol synthesis (squalene, desmosterol, and lathosterol) and absorption markers (campesterol, sitosterol, and stigmasterol) in the blood. Baseline hyperlipidemia patients displayed significantly higher total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels in comparison to the control group, which was reflected in the increased levels of squalene, desmosterol, campesterol, and sitosterol observed (P < 0.05) in the hyperlipidemia patients. The desmosterol, lathosterol, campesterol, stigmasterol, and sitosterol were statistically different in the FHC group than the hyperlipidemic group (P < 0.05). The proportions of squalene/cholesterol, lathosterol/cholesterol, stigmasterol/cholesterol, and sitosterol/cholesterol in the FHC group were lower than those in the hyperlipidemic group; only desmosterol/cholesterol was higher than that in the hyperlipidemic group. Correlation studies between lipid metabolic factors showed that the proportion of moderate and strong correlations was much higher in the FHC group than in the other two groups (76.92% vs. 32.50% and 31.25%). Logistic regression analysis showed that the concentrations of glucose, LDL-C, lactosterol, and sitosterol were all independent risk factors for developing hyperlipidemia. This result was further confirmed by the ROC curve. These results indicated that the study of cholesterol synthesis and decomposition markers can serve as a reference index for related diseases caused by changes in its concentration.
format Online
Article
Text
id pubmed-9050270
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90502702022-04-29 Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia Li, Zhi-Zhao Huang, Qiong Yang, Xiao-li Zeng, Jieqiong Wang, QI-Hui Tang, Hai-Ming Yu, Zhen-qiu Song, Yu-Qing Liu, Yang Dis Markers Research Article The cholesterol metabolism in humans can be indirectly reflected by measuring cholesterol metabolism marker levels. We aimed to investigate the association of cholesterol homeostasis markers on standard lipid profiling components in familial hypercholesteremia and hyperlipidemia patients. A total of 69 hyperlipidemia patients, 25 familial hypercholesteremia (FHC) patients, and 64 healthy controls were enrolled in this study. We performed routine testing of blood lipid water. Gas chromatography was used to determine the changes in the concentration of cholesterol synthesis (squalene, desmosterol, and lathosterol) and absorption markers (campesterol, sitosterol, and stigmasterol) in the blood. Baseline hyperlipidemia patients displayed significantly higher total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels in comparison to the control group, which was reflected in the increased levels of squalene, desmosterol, campesterol, and sitosterol observed (P < 0.05) in the hyperlipidemia patients. The desmosterol, lathosterol, campesterol, stigmasterol, and sitosterol were statistically different in the FHC group than the hyperlipidemic group (P < 0.05). The proportions of squalene/cholesterol, lathosterol/cholesterol, stigmasterol/cholesterol, and sitosterol/cholesterol in the FHC group were lower than those in the hyperlipidemic group; only desmosterol/cholesterol was higher than that in the hyperlipidemic group. Correlation studies between lipid metabolic factors showed that the proportion of moderate and strong correlations was much higher in the FHC group than in the other two groups (76.92% vs. 32.50% and 31.25%). Logistic regression analysis showed that the concentrations of glucose, LDL-C, lactosterol, and sitosterol were all independent risk factors for developing hyperlipidemia. This result was further confirmed by the ROC curve. These results indicated that the study of cholesterol synthesis and decomposition markers can serve as a reference index for related diseases caused by changes in its concentration. Hindawi 2022-04-21 /pmc/articles/PMC9050270/ /pubmed/35493299 http://dx.doi.org/10.1155/2022/2008556 Text en Copyright © 2022 Zhi-Zhao Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Zhi-Zhao
Huang, Qiong
Yang, Xiao-li
Zeng, Jieqiong
Wang, QI-Hui
Tang, Hai-Ming
Yu, Zhen-qiu
Song, Yu-Qing
Liu, Yang
Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
title Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
title_full Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
title_fullStr Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
title_full_unstemmed Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
title_short Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
title_sort cholesterol metabolic markers for differential evaluation of patients with hyperlipidemia and familial hypercholesterolemia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050270/
https://www.ncbi.nlm.nih.gov/pubmed/35493299
http://dx.doi.org/10.1155/2022/2008556
work_keys_str_mv AT lizhizhao cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT huangqiong cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT yangxiaoli cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT zengjieqiong cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT wangqihui cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT tanghaiming cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT yuzhenqiu cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT songyuqing cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia
AT liuyang cholesterolmetabolicmarkersfordifferentialevaluationofpatientswithhyperlipidemiaandfamilialhypercholesterolemia